MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
111 S. Wood Avenue
Phone
+1 609 619-3990
Employees
17
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHUJX53.841.91
+3.68%
JPMorgan Emerging Markets Equity R2
JISGX27.300.71
+2.67%
JPMorgan Small Cap Growth L
SMCIX25.000.45
+1.83%
Shelton S&P Smallcap Index Investor
BABDX12.860.14
+1.10%
BlackRock Global Dividend Inv A
NWXVX12.220.05
+0.41%
Nationwide International Sm Cp Instl Svc

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with LNAI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then LNAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
-4.24%
LNAI - OTLK
39%
Loosely correlated
-5.50%
GNPX - OTLK
38%
Loosely correlated
+22.47%
APVO - OTLK
37%
Loosely correlated
-2.71%
CANF - OTLK
34%
Loosely correlated
-1.65%
CYTK - OTLK
33%
Loosely correlated
+0.86%
More
Outlook Therapeutics (OTLK) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com